Limbs Range of Motion Exercises Along With Chest Physical Therapy After Correction of Congenital Heart Diseases in ICU

Congenital Heart Disease Clinical Trial

Official title:

Effect of Limbs Range of Motion Exercises Along With Chest Physical Therapy on Cardiopulmonary Parameters After Correction of Congenital Heart Diseases in ICU

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05425173
• Other study ID #: Muneeba Gul
• Status: Completed
• Phase: N/A
• Start date: June 20, 2022
• Est. completion date: December 30, 2022

Study information

• Verified date: January 2023
• Source: Riphah International University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

1. To determine the effect of limb ROMs along with chest Physical therapy on cardiopulmonary parameters after correction of congenital heart diseases in ICU

2. To determine the response of Inotropic drug in relation to Limb ROMs after Correction of Congenital heart diseases in ICU

Recruitment information / eligibility

• Status: Completed
• Enrollment: 20
• Est. completion date: December 30, 2022
• Est. primary completion date: December 30, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A to 5 Years

Eligibility

Inclusion Criteria:

• Patients below the age 5 years old that underwent congenital heart surgery.

Exclusion Criteria:

• Contraindications for exercise, mental retardation, unstable hemodynamics

Related Conditions & MeSH terms

• Congenital Heart Disease
• Heart Defects, Congenital
• Heart Diseases

Intervention

Other:
• Conventional treatment
Chest Physical Therapy as required
• Limb Range of Motion Exercises + Chest Physical Therapy
Limb Range of Motion Exercises + Chest Physical Therapy Frequency: 4 sessions Time: 5 to 10 minutes

Locations

Country	Name	City	State
Pakistan	Rehman Medical Institute	Peshawar	Khyber PkahtoonKhwa

Sponsors (1)

Lead Sponsor	Collaborator
Riphah International University

Country where clinical trial is conducted

Pakistan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Heart Rate	Changes from baseline, Heart rate was measured per minute through cardiac monitor	Upto 10 days
Primary	Respiration Rate	Changes from baseline,respiratory rate was measured per minute through cardiac monitor	Upto 10 days
Primary	Systolic Blood Pressure	Changes from the Baseline, Blood pressure is measured through sphygmomanometer	Upto 10 days
Primary	Diastolic Blood Pressure	Changes from the Baseline, Blood pressure is measured through sphygmomanometer	Upto 10 days
Primary	Partial pressure of oxygen	Changes from the Baseline, Blood pressure is measured through sphygmomanometer	Upto 10 days
Primary	Partial Pressure of carbon dioxide	Changes from the Baseline, Blood pressure is measured through sphygmomanometer	Upto 10 days
Primary	Arterial blood gas (ABG) parameter like potential of hydrogen (PH)	Above parameter was measured by serial ABG analysis. Its normal reference range is 7.35-7.45. baseline reading will be taken at 10 minutes before starting Non invasive ventilation training. Changes from the Baseline	Upto 10 days
Primary	Arterial blood gas parameter like bicarbonate(HCO3).	Above parameter was measured by serial ABG analysis. Its normal reference range is 22-28 nmol/L. Baseline reading will be taken at 10 minutes before starting Non invasive ventilation training. Changes from the Baseline	Upto 10 days
Primary	Oxygen saturation	Changes from baseline SPO2 was measured in percentage. Oxygen immersion is the division of oxygen-soaked hemoglobin with respect to add up to hemoglobin in the blood. Pulse oximeter measure it.	Upto 10 days
Primary	Ejection fraction	Change from baseline Ejection fraction through Echocardiography	Upto 10 days